Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke

Early reperfusion therapy with tissue plasminogen activator (tPA) for acute ischemic stroke has mortality benefits despite the risks. Myocardial infarction (MI) after the use of thrombolytic therapy is a rare complication. We report a 67-year-old woman with acute stroke who received tPA for acute is...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohmand, Billal, Naqvi, Abeeha, Singh, Avneet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388234/
https://www.ncbi.nlm.nih.gov/pubmed/34462690
http://dx.doi.org/10.7759/cureus.16659
Descripción
Sumario:Early reperfusion therapy with tissue plasminogen activator (tPA) for acute ischemic stroke has mortality benefits despite the risks. Myocardial infarction (MI) after the use of thrombolytic therapy is a rare complication. We report a 67-year-old woman with acute stroke who received tPA for acute ischemic stroke and subsequently developed ST elevation MI (STEMI), highlighting a rare and serious complication. 

Ejemplares similares